These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 499089)

  • 1. Effect of prostaglandin E1 on renin and aldosterone in hypertensive patients.
    Yoshimura M; Takahashi H; Takashina R; Kajita Y; Miyazaki T; Hachiya T; Ijichi H; Ochi Y
    Endocrinol Jpn; 1979 Aug; 26(4):481-6. PubMed ID: 499089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pressor agents on blood pressure, plasma renin activity and plasma aldosterone concentration in essential hypertension.
    Yamamoto Y
    Jpn Heart J; 1975 Jul; 16(4):404-20. PubMed ID: 1152295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between propranolol in plasma and urine, renin-aldosterone system and blood pressure in essential hypertension.
    Pedersen EB; Kornerup HJ; Pedersen OL; Andreasen F; Bjerregaard P
    Eur J Clin Pharmacol; 1981; 20(4):251-8. PubMed ID: 7030750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of plasma renin activity by indomethacin in man.
    Frölich JC; Hollifield JW; Dormois JC; Frölich BL; Seyberth H; Michelakis AM; Oates JA
    Circ Res; 1976 Sep; 39(3):447-52. PubMed ID: 821675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of angiotensin III on blood pressure, renin-angiotensin-aldosterone system in normal and hypertensive subjects.
    Suzuki S; Doi Y; Aoi W; Kuramochi M; Hashiba K
    Jpn Heart J; 1984 Jan; 25(1):75-85. PubMed ID: 6376863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Renin and aldosterone secretion under converting enzyme inhibition].
    Nakamura K
    Nihon Naibunpi Gakkai Zasshi; 1983 Aug; 59(8):1099-116. PubMed ID: 6141075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of propranolol on the urinary excretion of prostaglandin E and plasma renin activity in hypertensive patients.
    Sato M; Abe K; Yasujima M; Otsuka Y; Chiba S; Haruyama T; Sato K; Imai Y; Sakurai Y; Ito T; Omata K; Yoshinaga K
    Prostaglandins Med; 1980 Jul; 5(1):1-9. PubMed ID: 6996018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma renin activity and aldosterone concentration are not altered by the novel calcium channel antagonist, azelnidipine, in hypertensive patients.
    Kondo T; Goto R; Sonoda K; Yasuda T; Ono K; Takaki Y; Yatsuda R; Miyamura N; Araki E
    Intern Med; 2010; 49(7):637-43. PubMed ID: 20371952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of an angiotensin II antagonist; [sarcosine 1, isoleucine 8] angiotensin II, on blood pressure, plasma renin activity and plasma aldosterone concentration in hypertensive and normotensive subjects taking oral contraceptives.
    Ogihara T; Hata T; Maruyama A; Nakamaru M; Mikami H; Kumahara Y
    Endocrinol Jpn; 1979 Oct; 26(5):591-7. PubMed ID: 393505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of plasma renin activity by inhibition of the fatty acid cyclooxygenase in human subjects: independence of sodium retention.
    Frölich JC; Hollifield JW; Michelakis AM; Vesper BS; Wilson JP; Shand DG; Seyberth HJ; Frölich WH; Oates JA
    Circ Res; 1979 Jun; 44(6):781-7. PubMed ID: 218749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of magnesium on the renin-angiotensin-aldosterone system in human subjects.
    Ichihara A; Suzuki H; Saruta T
    J Lab Clin Med; 1993 Oct; 122(4):432-40. PubMed ID: 8228558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of prostaglandin A1 on renin and aldosterone in man.
    Golub MS; Speckart PF; Zia PK; Horton R
    Circ Res; 1976 Oct; 39(4):574-9. PubMed ID: 963841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An abnormal sodium metabolism in Japanese patients with essential hypertension, judged by serum sodium distribution, renal function and the renin-aldosterone system.
    Komiya I; Yamada T; Takasu N; Asawa T; Akamine H; Yagi N; Nagasawa Y; Ohtsuka H; Miyahara Y; Sakai H; Sato A; Aizawa T
    J Hypertens; 1997 Jan; 15(1):65-72. PubMed ID: 9050972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circadian changes in plasma renin activity and plasma aldosterone concentration in two-kidney hypertension rats.
    DeForrest JM; Davis JO; Freeman RH; Stephens GA; Watkins BE
    Hypertension; 1979; 1(2):142-9. PubMed ID: 399940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of indomethacin on plasma renin activity and urinary aldosterone of patients with essential hypertension.
    Pedrinelli R; Arzilli F; Cavasinni L; Poli L; Sassano P; Salvetti A
    J Endocrinol Invest; 1978 Oct; 1(4):315-20. PubMed ID: 756881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative association between plasma aldosterone concentration/plasma renin activity and morning blood pressure surge in never-treated hypertensive patients.
    Cho JS; Ihm SH; Jang SW; Chung WB; Choi YS; Shin DI; Seo SM; Park MW; Kim GH; Her SH; Kim CJ; Kim TH; Kang MK; Chang K; Park CS
    Clin Exp Hypertens; 2014; 36(4):195-9. PubMed ID: 24678899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of chronic beta-adrenergic blockade on blood pressure and release of renin, aldosterone and cortisol in essential hypertension (author's transl)].
    Stumpe KO; Vetter H; Hessenbruch V; Düsing R; Kolloch R; Krück F
    Klin Wochenschr; 1975 Oct; 53(19):907-11. PubMed ID: 241876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of 6-oxo-PGE1 on the renin-angiotensin-aldosterone system, blood pressure and platelet aggregability in man].
    Morise T; Miyamori I; Ikeda M; Takeda Y; Koshida H; Yasuhara S; Takeda R
    Nihon Naibunpi Gakkai Zasshi; 1983 Aug; 59(8):1138-44. PubMed ID: 6686560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of indomethacin and (+/-)-propranolol on the cardiovascular and renin responses to vasoactive intestinal polypeptide (VIP) infusion in man.
    Unwin RJ; Reed T; Thom S; Calam J; Peart WS
    Br J Clin Pharmacol; 1987 May; 23(5):523-8. PubMed ID: 3297124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.